Prevalence of metabolic syndrome in ankylosing spondylitis: a multi national meta-analysis study.

ABSTRACT:

Background

Ankylosing spondylitis (AS) is a chronic inflammatory disease associated with an increased risk of metabolic syndrome (MetS), a cluster of cardiometabolic risk factors. However, the prevalence of MetS in AS remains uncertain. This meta-analysis estimates the global prevalence of MetS in AS patients and identifies factors contributing to its variability.

Methods

A systematic search of PubMed, Scopus, Embase, and Web of Science was conducted for studies published up to January 18, 2024. A random-effects model was used to estimate pooled prevalence, while meta-regression and subgroup analyses explored sources of heterogeneity.

Results

Seventeen studies meeting the eligibility criteria were included. The pooled prevalence of MetS in AS patients was 15.5% (95% c

SUBMITTER: Nayak SS 

PROVIDER: S-EPMC12082907 | biostudies-literature | 2025 May

REPOSITORIES: biostudies-literature